Evidence map›Paper›PMID 23445875›Full record

Trial reportHaematologica2013

Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy.

Alan E Mast, Karen S Schlumpf, David J Wright, Bryce Johnson, Simone A Glynn, Michael P Busch, Gordana Olbina, Mark Westerman, Elizabeta Nemeth, Tomas Ganz and 1 more

Registry-linked trialOpen access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Haematologica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00097006 (Retrovirus Epidemiology Donor Study-II), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00097006 completednot on this map

Retrovirus Epidemiology Donor Study-II (REDS-II)

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2004 to 2009ConditionsAcquired Immunodeficiency Syndrome, Blood Donors, Blood Transfusion, HIV Infections
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Iron as a Therapeutic Target inPharmaceuticals (Basel, Switzerland) · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Low hemoglobin deferral in blood donors.Transfusion medicine reviews · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Alan E MastBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, USA. alan.mast@bcw.edu
Karen S Schlumpf
David J Wright
Bryce Johnson
Simone A Glynn
Michael P Busch
Gordana Olbina
Mark Westerman
Elizabeta Nemeth
Tomas Ganz
NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II)
Westat (United States) · USIntrinsic LifeSciences (United States) · USUniversity of California, Los Angeles · USBlood Systems Research Institute · USNational Heart Lung and Blood Institute · USVersiti Blood Center of Wisconsin · US

Funding

REDS-II Central Laboratory-268047175-268047175N01HB047175 · HB · WESTAT. INC. · PI BUSCH, MICHAEL PAUL · 2005 to 2006
–
NHLBI NIH HHS N01 HB047168NHLBI NIH HHS N01 HB047169NHLBI NIH HHS N01-HB-47168NHLBI NIH HHS N01-HB-47169NHLBI NIH HHS N01-HB-47170NHLBI NIH HHS N01-HB-47171NHLBI NIH HHS N01-HB-47172NHLBI NIH HHS N01-HB-47174NHLBI NIH HHS N01-HB-47175NHLBI NIH HHS N01-HB-57181
6 · The paper itself

Abstract

Dietary iron absorption is regulated by hepcidin, an iron regulatory protein produced by the liver. Hepcidin production is regulated by iron stores, erythropoiesis and inflammation, but its physiology when repeated blood loss occurs has not been characterized. Hepcidin was assayed in plasma samples obtained from 114 first-time/reactivated (no blood donations in preceding 2 years) female donors and 34 frequent (≥3 red blood cell donations in preceding 12 months) male donors as they were phlebotomized ≥4 times over 18-24 months. Hepcidin levels were compared to ferritin and hemoglobin levels using multivariable repeated measures regression models. Hepcidin, ferritin and hemoglobin levels declined with increasing frequency of donation in the first-time/reactivated females. Hepcidin and ferritin levels correlated well with each other (Spearman's correlation of 0.74), but on average hepcidin varied more between donations for a given donor relative to ferritin. In a multivariable repeated measures regression model the predicted inter-donation decline in hemoglobin varied as a function of hepcidin and ferritin; hemoglobin was 0.51 g/dL lower for subjects with low (>45.7 ng/mL) or decreasing hepcidin and low ferritin (>26 ng/mL), and was essentially zero for other subjects including those with high (>45.7 ng/mL) or increasing hepcidin and low ferritin (>26 ng/mL) levels (P<0.001). In conclusion, hepcidin levels change rapidly in response to dietary iron needed for erythropoiesis. The dynamic regulation of hepcidin in the presence of a low levels of ferritin suggests that plasma hepcidin concentration may provide clinically useful information about an individual's iron status (and hence capacity to tolerate repeated blood donations) beyond that of ferritin alone. Clinicaltrials.gov identifier: NCT00097006.

Indexed as

Blood DonorsAdolescentAdultFemaleHemoglobinsHepcidinsHumansLongitudinal StudiesMaleMiddle AgedPhlebotomyPredictive Value of TestsTime FactorsYoung AdultHemoglobinsHepcidins

Identifiers

PMID23445875
PMCPMC3729915
OpenAlexW2013071898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.